A Precision-Medicine Initiative Sponsored by the National Cancer Institute Aims to Improve Treatment for the Most Common Form of Leukemia in Adults

The University of Kansas Cancer Center is part of the myeloMATCH trial, a large, coordinated effort to improve patient outcomes through targeted treatments for people with acute myeloid leukemia or myelodysplastic syndrome. 

Read More